Insmed Incorporated (INSM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Group 1 - The company has experienced significant growth in value and patient hope over the past 12 to 18 months, with potential for even greater achievements in the future [4] - The company currently has three programs in clinical/commercial stages, with a focus on ARIKAYCE, which has been a commercial product for over seven years [5]